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Abstract: 28 
Reactive oxygen species play an important role in cancer, however, their promiscuous 29 
reactivity, low abundance and short-lived nature limits our ability to study them in real time in 30 
living subjects with conventional non-invasive imaging methods. Photoacoustic imaging is an 31 
emerging modality for in vivo visualization of molecular processes with deep tissue penetration 32 
and high spatio-temporal resolution. Here, we describe the design and synthesis of a targeted, 33 
activatable probe for photoacoustic imaging, which is responsive to one of the major and 34 
abundant reactive oxygen species, hydrogen peroxide (H2O2). This bifunctional probe, which 35 
is also detectable with fluorescence imaging, is composed of a heptamethine carbocyanine 36 
dye scaffold for signal generation, a 2-deoxyglucose cancer localization moiety and a boronic 37 
ester functionality that specifically detects and reacts to H2O2. We characterized the optical 38 
properties of the probe using absorption, fluorescence and photoacoustic measurements and 39 
quantified changes in these properties upon addition of pathophysiological H2O2 40 
concentrations. We then evaluated the promise of the probe in vitro, including cell uptake and 41 
biocompatibility. Importantly, we showed that this probe is suitable for targeted non-invasive, 42 
real-time in vivo imaging of H2O2 in solid tumors. 43 
Significance:  44 
This study presents the first activatable and cancer-targeted hydrogen peroxide probe for 45 
photoacoustic molecular imaging, paving the way for visualization of hydrogen peroxide at 46 
high spatio-temporal resolution in living subjects 47 
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Introduction  49 
Reactive oxygen species (ROS) are generated as a normal by-product of respiration and at 50 
low concentrations act as signaling molecules. Oxidative stress arises when the concentration 51 
of ROS exceeds the capacity of intracellular antioxidant systems and plays a key role in the 52 
progression of a range of pathologies,1 including cancer, as well as neurodegenerative and 53 
cardio-vascular diseases.2 For example, a sustained oxidative environment can lead to 54 
malignant transformation. Once transformed, aberrant cancer cell proliferation and 55 
metabolism together with a complex tumor microenvironment leads to very high levels of 56 
ROS.3 Cancer cells must therefore tightly regulate their antioxidant capacity to survive this 57 
ROS exposure; the ability to endure prolonged and severe oxidative stress has been strongly 58 
associated with cancer aggressiveness and drug resistance. 59 
Our current understanding of how oxidative stress contributes to cancer progression, and 60 
whether strategies to abrogate this adaptive response can be used to modify therapy 61 
response, are fundamentally limited by a lack of tools with which to study redox processes 62 
with sufficient spatio-temporal resolution in living subjects.4 Fortunately, photoacoustic 63 
imaging (PAI) operates on a regime highly suited to meet these needs. PAI is an emerging 64 
molecular imaging modality that enables non-invasive, real-time visualization of cellular and 65 
molecular processes in living subjects with a spatial resolution of ~100 μm at depths of several 66 
centimeters. It is based on the photoacoustic effect, in which acoustic waves are generated in 67 
response to the absorption of short light pulses and subsequent tissue heating. Since sound 68 
waves are less scattered by biological tissues than photons, this technique bypasses some of 69 
the drawbacks of traditional optical imaging techniques and combines the high temporal and 70 
spatial resolution of ultrasound with the high contrast of optical imaging.5  71 
Optically absorbing chromophores intrinsic to living subjects (e.g. hemoglobin, melanin and 72 
lipids) enable PAI to provide structural and functional imaging. A great variety of signaling 73 
compounds used as contrast agents for PAI have already been reported to enable PA 74 
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molecular imaging, including small molecule near-infrared dyes, inorganic and organic 75 
nanostructures.6 Probes that are targeted and activatable are of particular interest since they 76 
preferentially accumulate in a specific tissue type and then elicit a signal change upon binding 77 
or interaction with their target biological process. These two features reduce the impact of the 78 
physiological background signals and increase the potential for signal quantification. A PAI 79 
probe tailored for the detection of ROS in disease must: be non-toxic; avoid promiscuous 80 
reactivity at normal physiological ROS concentrations or with multiple ROS; be highly sensitive 81 
to the ROS of interest; and accumulate in the tissue of interest to allow disease-specific 82 
readout. 83 
In this study, we created the first activatable and cancer-targeted H2O2 probe providing dual 84 
contrast in photoacoustic and fluorescence imaging that satisfies these criteria. H2O2 is a major 85 
and abundant ROS with a relatively high chemical stability involved in cell signaling and 86 
strikingly increased in cancer cells.7 There are several reports describing boronic acid/esters 87 
as specific masking groups, which are chemoselectively removed by H2O2 over competing 88 
ROS.8–10 Based on this foreknowledge, we designed a smart, targeted near-infrared PAI probe 89 
composed of: a heptamethine carbocyanine backbone;11 an aryl boronate ester reactive 90 
towards H2O2 connected to the dye backbone via a linker structure; and 2-deoxyglucose as a 91 
targeting moiety to direct the probe preferentially to cancerous tissue.12–14 The resulting probe, 92 
JW41, allows the effective and selective detection of pathological H2O2 concentrations via 93 
absorption, fluorescence and photoacoustic spectroscopy. Importantly, we demonstrate the 94 
ability of the activatable probe to detect tumor specific H2O2-levels in a subcutaneous mouse 95 
model of breast cancer in vivo. Future in vivo application of this new targeted, activatable 96 
probe could provide unprecedented insight into the role of oxidative stress in cancer at high 97 
temporal and spatial resolution in living subjects. 98 
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Materials and Methods 100 
Synthesis 101 
The preparation and characterization of JW35 and JW41 as depicted in Figure 1 and 102 
Supporting Figure 1 are documented in the Supporting Methods. 103 
Optical Characterization 104 
Absorption maxima (λAbs), emission maxima (λEm), Stokes shift, molar extinction coefficient (ε), 105 
fluorescence quantum yield (FFl) and brightness (B) were determined. Stokes shifts were 106 
calculated from the difference of λEm and λAbs. ε was determined using the Beer–Lambert law 107 
from dilutions of solutions with known concentrations. FFl of JW41 and JW35 in water, MeOH 108 
and EtOH/H2O (7/3) were measured at the excitation wavelength of 785 nm and referenced 109 
against 1,1′,3,3,3′,3′-Hexamethylindotricarbocyanine iodide (HITC, 252034, Sigma-Aldrich) in 110 
MeOH (FFl=0.28)15. Discrepancies in absorbance and solvent refractive index were 111 
corrected16. To assess the optical responses of JW41 to H2O2 the probe was incubated with 112 
100μM H2O2 (pH=6.15) and the absorption, fluorescence and PA spectra recorded before and 113 
up to 90min after addition of H2O2 at either 5min intervals over the whole period or at 1min 114 
intervals for the first 10min followed by 5min intervals. JW41 in water without the H2O2 115 
supplement served as control. To prove that the product of the reaction, JW35, does not react 116 
further, the same measurements were performed with JW35. Selectivity to H2O2 was 117 
confirmed using LCMS (Supporting Methods). All experiments were repeated with n=3 118 
separately prepared probe samples and errors are represented as standard deviations.  119 
To study the photostability of the probes for in vivo applications and potential for spectral 120 
unmixing, phantoms with defined optical properties closely mimicking the optical properties of 121 
biological tissue were fabricated, imaged and analyzed as described previously17 and further 122 
elaborated in the Supporting Methods. Photoacoustic signals were recorded using 25 different 123 
excitation wavelengths between 660nm and 900nm. 124 
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In vitro cell experiments 125 
The two human adenocarcinoma cell lines MDA-MB-231 (Estrogen Receptor−, ER−) and 126 
MCF-7 (Estrogen Receptor+, ER+) were obtained from the Cancer Research UK (CRUK) 127 
Cambridge Institute Biorepository Core Facility at the University of Cambridge and 128 
mycoplasma tested. The experiments were performed when cells were between passage 22 129 
to 35 for MCF-7 and between passage 30 to 43 for MDA-MB-231. Authentication using 130 
Genemapper ID v3.2.1 (Genetica) by STR Genotyping (11/2017) showed exact match with 131 
the reference sequence in both cases. Cells were maintained in Dulbecco’s Modified Eagle 132 
Medium (21885-025, ThermoFisher Scientific) with 10% heat inactivated fetal calf serum 133 
(1050064, ThermoFisher Scientific) at 37 °C in 5% CO2. The cells were routinely subcultured 134 
when reaching 85% confluence (1:10 for MCF-7 and 1:20 for MDA-MB-231).  135 
Full details of all in vitro experiments can be found in the Supporting Methods. Cellular toxicity 136 
of the probes was examined by quantifying cell proliferation and viability via standard MTT (3-137 
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and IncuCyte proliferation 138 
assay. GLUT-dependent uptake kinetics and localization of JW41 as well as JW35 were 139 
examined in MDA-MB-231 and MCF7 cells using standard fluorescent assays and 140 
epifluorescent microscopy. The fluorescence of JW41/35 was collected upon excitation at 141 
770nm. Cells were also stained with: MitoTracker Orange (excitation 580nm); LysoTracker 142 
green (excitation 490nm) and NucBlue/Hoechst (excitation 365nm). Zen 2.3 (blue edition) was 143 
used for image analysis.  144 
In vivo studies 145 
All animal procedures conducted meet the standards required by the UKCCCR guidelines and 146 
were performed under the authority of project and personal licenses issued by the Home 147 
Office, U.K., reviewed by the Animal Welfare and Ethical Review Board at the CRUK 148 
Cambridge Institute. 300,000 MDA-MB-231 cells in a final volume of 100μL of 1:1 DMEM 149 
(GIBCO) and matrigel (BD) were inoculated orthotopically in the mammary fat pad of both 150 
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flanks of 10 seven-week-old immunodeficient female nude (BALB/c nu/nu) mice (Charles 151 
River). All mice were kept with 5R58 diet (PicoLab) in Tecniplast Green Line cages, 152 
individually ventilated in 12/12 h ON/OFF light cycles. Tumors were measured externally with 153 
Vernier calipers. The probe was injected and the mouse imaged when tumor size was between 154 
0.5 and 1cm diameter. Animals were killed by exsanguination and cervical dislocation as 155 
confirmation of death. Tumors, liver, kidney, spleen, heart and brain were collected for ex vivo 156 
analysis. Afterwards, tumors and livers were divided into 3 parts for histopathology, 157 
microscopy and LC-MS/MS analysis. Kidney, spleen, heart and brain were paraffin 158 
embedded. One mouse developed only one tumor that could be fully analyzed and one small 159 
tumor, which was not analyzed ex vivo.  160 
PA in vivo imaging 161 
All PA in vivo imaging was performed with the photoacoustic imaging system described in 162 
Supporting Methods (inVision 256-TF, iThera Medical GmbH) and mice were prepared for 163 
imaging following our standard operating procedure17. Briefly, <3% isoflurane was used to 164 
anesthetize the mice before they were placed in a custom animal holder (iThera Medical), 165 
wrapped in a thin polyethylene membrane. A thin layer of ultrasound gel (Aquasonic Clear, 166 
Parker Labs) was used to couple the skin to the membrane. The holder was then placed within 167 
the PA system and immersed in heavy water maintained at 36°C. The respiratory rate of the 168 
mice was maintained in the range of 70–80b.p.m. with 1.5–2% isoflurane concentration for the 169 
entire scan time. 5min after the animal was placed into the imaging system, the scan was 170 
initialized and the baseline was monitored for further 14min, to stabilize the signal. 14min into 171 
the scan 150µL of the probe in saline (9mg/mL; pH=4.93) was injected intravenously in the 172 
tail vein for a 20g mouse at a concentration of 150µM for JW41, 50µM for JW35 and 100µM 173 
JW41 + 50µM JW35 for the 2-1 mixture. Images were acquired at one slice centered on the 174 
liver, one slice centered on the kidneys, spleen and liver, and several slices covering the whole 175 
length of both tumors in 1-mm steps. Scans were recorded at 21 wavelengths between 660nm 176 
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and 900nm with 10 averages (continuous averaging) for up to 50min in 5min intervals. 24h 177 
after injection of the probe the mouse was imaged once again.  178 
Image analysis of PA in vivo data 179 
The acquired images were reconstructed offline with model-linear reconstruction and analyzed 180 
with linear regression multispectral processing (ViewMSOT version 3.8; iTheraMedical). 181 
Linear regression was performed with published spectra for oxy- and deoxyhemoglobin as 182 
well as JW41 and JW35 spectra obtained from our phantom studies. Regions of interest 183 
(ROIs) were drawn around the liver, left kidney, spleen and tumors as identified using the 184 
hemoglobin signals as an anatomical reference. Reference values from ROIs drawn as 185 
indicated were taken in the same anatomical plane. The PA spectra in the imaged organs 186 
were generated by averaging the mean pixel signal intensities of each ROI from every section. 187 
For the PA tumor spectra, the average of all tumor spectra of each tomographic section was 188 
formed. To correct for the intrinsic background signal, the PA signal recorded at t=0 was 189 
subtracted from the subsequent images. To monitor the kinetics of the probe in the different 190 
organs, the raw mean pixel intensity values at 760nm and 900nm were used and the ratio was 191 
formed.  To generate the PA signal kinetic plot based on the spectral unmixing data obtained 192 
by linear regression, the values obtained before injection of the probe in the ROI were 193 
averaged and used as baseline to allow comparison with the 24h time point signal.  194 
In vivo fluorescence imaging 195 
In vivo fluorescence imaging was carried out on a Xenogen IVIS 200 system. The 196 
anaesthetized animal was imaged before the injection of the probe and acquiring the PA 197 
scans, after the PA image acquisition, then 50-60min post injection of the probe, as well as 24 198 
h post injection. Scans were recorded with filter set 4 using 705–780nm as the excitation 199 
passband, 810–885nm as the emission passband and 665–696nm as the background 200 
passband. Autofluorescence was corrected by subtracting the background filter image from 201 
the primary filter image. ROIs were drawn on the black and white photographic image of the 202 
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mouse without displaying the fluorescence signal. The average radiant efficiency obtained in 203 
the control region C was subtracted from the average radiant efficiency within the ROI. 204 
Ex vivo characterization 205 
Tumors were divided into 3 parts, which were either mounted on a cork base using optimal 206 
cutting temperature solution (VWR Chemicals) and snap frozen in an isopentane bath cooled 207 
to -60°C for fluorescence analysis, snap frozen in liquid nitrogen for LC-MS/MS analysis or 208 
fixed in neutral buffered 10% formalin (24h) for hematoxylin and eosin (H&E) staining. Livers 209 
were divided in 2 parts, one was snap frozen for LC-MS/MS analysis, the other one fixed in 210 
neutral buffered 10% formalin (24h) for H&E staining. Formalin fixed, paraffin embedded 211 
tumors and livers were sectioned with 3µm and imaged at ×20 magnification using an Aperio 212 
ScanScope (Leica Biosystem) scanner. Frozen blocks were sectioned with 6µm thickness. 2 213 
consecutive slices were generated, of which one was stained with H&E. The other section was 214 
fixed with 4% PFA for 5min at room temperature, washed carefully twice with PBS, mounted 215 
in mounting media with DAPI (ProLong™ Gold Antifade Mountant with DAPI, 216 
LifeTechnologies) and scanned using a wide-field fluorescent microscope (Zeiss Axio 217 
Observer Z1) with excitation wavelengths centered on 365nm (for DAPI) and on 740nm for 218 
JW41/JW35 under a 63x oil-immersion objective lens.  219 
The concentration of the activatable probe JW41 and its conversion product, JW35, in tissue 220 
samples were determined by LC-MS/MS against a reference standard solution (Supporting 221 
Fig. 2). JW41 hydrolyses under aqueous, acidic conditions gradually to JW41hydrol. Thus, 222 
JW35, JW41 and JW41hydrol were identified from their retention time and from their specific 223 
mass transition in multiple reaction monitoring mode (MRM-MS; Supporting Fig. 3). Full details 224 
of the preparation of quality control and internal standard solutions, along with details of the 225 
MRM-MS can be found in the Supporting Methods. 226 
Statistical analysis 227 
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Statistical analysis was performed using GraphPad Prism6. Each tumor was considered as 228 
an independent biological replicate. All data are shown as mean±SD. 229 
  230 
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Results  231 
Probe design and synthesis. To accurately map cellular redox conditions at depth in vivo by 232 
means of PAI, a characteristic change in the absorption spectrum in the near-infrared range 233 
must be produced upon interaction with the target redox species. We sought to achieve such 234 
a characteristic change by combining a near-infrared heptamethine carbocyanine backbone 235 
with a linker unit able to elicit a change in the optical properties of the dye backbone upon 236 
H2O2-specific reaction. Cyanine-based scaffolds with different linker structures were 237 
synthesized and investigated for their ability to trigger a signal change (Supporting Fig. 4, 238 
Supporting Methods). Our findings encouraged us to proceed with piperazine and an aryl 239 
boronate in para position to a benzylic carbamate linkage (Fig. 1, Supporting Fig. 1, Supporting 240 
Methods), which promotes the unique H2O2-mediated deprotection due to formation of the 241 
phenol and subsequent decarboxylation.18 242 
Experimentally measured changes in absorption after cleavage of the aryl boronate moiety in 243 
dyes with a piperazine linker structure were supported by density functional theory calculations 244 
(Supporting Fig. 5, Supporting Methods). These calculations suggest that the absorption 245 
change corresponds to a decreased twist [74.0° (JW41) vs 23.3° (JW35)] in the relative 246 
orientation of the two terminal benzoindole moieties going from the capped probe, JW41, to 247 
the uncapped derivative, JW35, with a consequence of improved electron-delocalization. 248 
Similar aromatic linkers did not lead to different absorption spectra, which was in accordance 249 
with a nearly identical twist (0.3° and 2.10°; Supporting Fig. 5) in the different derivatives.  250 
Photophysical properties. It is an essential requirement for the determination of H2O2 that 251 
the induced changes in absorption spectra precisely distinguish the capped (JW41) and 252 
uncapped (JW35) probe (Fig. 2; Supporting Table 1). The results suggest that the capped and 253 
uncapped probe are clearly distinguishable via absorption (Fig. 2A), fluorescence (Fig. 2B) 254 
and PA spectroscopy (Fig. 2C). The absorption and PA maxima of JW41 and JW35 appear 255 
in the near-infrared region with an offset of 60nm and 80nm respectively. The fluorescence 256 
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emission maximum is located at ~825nm for both forms, leading to a large Stokes shift of 257 
about 95 nm for JW41, affording an increase in signal-to-noise ratio for fluorescence imaging. 258 
Although the capped and uncapped probes showed emission maxima at around the same 259 
wavelength, the fluorescence intensity of the uncapped probe (FFl(JW35)=0.0123±0.0015) in 260 
aqueous environment increased by over 100% relative to the capped probe 261 
(FFl(JW41)=0.0063±0.0009), which can be reasoned by photoinduced electron transfer in the 262 
case of JW41. This is mirrored by the total integrated emission intensity (brightness, B) of the 263 
capped probe (457M-1cm-1) in water being half the brightness of the uncapped probe (951M-264 
1cm-1), with molar extinction coefficients respectively of εJW41(730nm)=61,400M-1cm-1 and 265 
εJW35(790nm)=77,450M-1 cm-1. Additionally, both probes showed promising photothermal stability 266 
for in vivo applications (Fig. 2D) compared to IR800CW, a near infrared dye already widely 267 
used in PAI.19,20 268 
Having identified a clear shift in the absorption spectrum of the uncapped probe, we then 269 
assessed the potential of PAI to accurately detect and quantify the relative concentrations of 270 
the capped and uncapped probe in tissue mimicking phantoms. The PA spectra of the two 271 
probes at 1 µM and the background obtained in a tissue mimicking phantom (Fig. 2D) served 272 
as endmembers for spectral unmixing using linear regression, which enabled identification of 273 
the capped or uncapped probe in solution (Fig. 2E). The accuracy (% deviation from the known 274 
concentration) for identification of the relative concentration in mixtures (JW35:JW41; 100:0, 275 
0:225, 66.6:33.3, 50:50, 33.3:66.6) when compared to a reference of 1 µM JW35 was found 276 
to be -6.0% and -5.6% for JW35 and JW41 respectively across the range of samples tested 277 
(Supporting Table 2). These findings illustrate the effective detection and separation of the 278 
two probes from each other and the background with a preciseness suited to detect changes 279 
in H2O2 under pathological conditions. 280 
ROS sensing. The ability of the capped probe, JW41, to respond to H2O2 with a change in its 281 
photophysical properties was next evaluated with absorption, fluorescence and PA 282 
spectroscopy following addition of 100µM H2O2, a physiologically realistic concentration in a 283 
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cellular environment undergoing oxidative stress.21 A rapid spectral change was observed 284 
following the addition of 100µM H2O2. The optical absorption peak at 730nm shifted by 60nm 285 
to 790nm and the absorbance at 790nm was found to increase by over 45% (Fig. 3A). 286 
Similarly, the photoacoustic peak shifted from 705nm to 785nm with an increase of the 785nm 287 
signal by 25% (Fig. 3B). Furthermore, the addition of H2O2 elicits a prompt increase in the 288 
fluorescence signal at 825nm by over 100% (Fig. 3C). The reaction kinetics could be followed 289 
with all three modalities, indicating a fast conversion of the capped probe into the uncapped 290 
probe over a period of 10 minutes (Fig. 3D). All measurements were cross validated via LC/MS 291 
confirming that the signal changes were caused by the conversion of JW41 to JW35 (Fig. 3E).  292 
These properties were specific to the radical species H2O2 with no cross-reactivity observed 293 
in a wide range of other radical species using LC/MS with UV monitoring (Fig. 3E). The 294 
generation of the different radical species was verified independently using standard methods. 295 
As the oxidation reaction is irreversible, this probe records the total H2O2 exposure to the 296 
system, rather than an equilibrium value. 297 
In vitro evaluation. Both probes showed good stability in plasma at 37°C with no significant 298 
formation of degradation product detected after 2h (Supporting Fig. 6A). Protein binding not 299 
only influences the optical properties of dyes but also hampers extravasation and hence 300 
affects the biodistribution of a contrast agent (e.g. by increasing hepatic clearance). Both 301 
JW35 and JW41 bound more strongly to protein than a low protein binding dye (IR800CW) 302 
but considerably less than a strongly protein binding dye (ICG) (Supporting Fig. 6B).22 303 
To establish the toxicity and uptake profiles of the new probe, two breast cancer cell lines, 304 
MCF-7 and MDA-MB-231, were used. These two cell lines differ significantly in their ROS 305 
production abilities23 and MDA-MB-231 cells typically express higher levels of glut1 mRNA 306 
than MCF7 cells24 (Supporting Fig. 6C). The cytotoxicity of the capped and uncapped probe 307 
was tested via MTT viability assay and IncuCyte proliferation assay. Neither the capped or 308 
uncapped probes showed any significant cytotoxicity over 5 days in the cell lines tested (Fig. 309 
4A, B).  310 
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Next, we investigated the cellular uptake of the new probe using the fluorescence capability 311 
in microscopy. In cell studies with MCF-7 and MDA-MB-231, addition of 5µM JW41/JW35 312 
resulted in a rapid cellular uptake already after 15min, with continued increases observed over 313 
4h (Fig. 4C). To more precisely identify the intracellular localization, microscopic examination 314 
of live and fixed MDA-MB-231 and MCF7 cells by wide field microscopy were performed. Co-315 
staining with Hoechst for nuclear localization, WGA-AF488 for membrane staining, 316 
MitoTracker orange for mitochondrial staining and LysoTracker green for lysosomal staining, 317 
suggest that the observed signal from JW41 and JW35 can be localized to the cytosol of the 318 
cells with no nuclear or cell surface colocalization (Fig. 4D and Supporting Fig. 6D).  319 
Finally, to establish the GLUT targeting ability of the probe and to test whether the cellular 320 
uptake is GLUT-mediated, we performed a 12-O-tetradecanoylphorbol-13-acetate (TPA) 321 
uptake assay. TPA generates a rapid upregulation of cell surface localization of GLUT1 322 
resulting in an increased glucose uptake.25 This facilitation of glucose transport resulted in an 323 
increase in JW41 uptake. IR800CW was used as a negative control without targeting moiety 324 
and IR800CW-2DG as a positive control.26 This control pair was chosen due to the similarity 325 
in targeting structure, molecular weight and near-infrared absorption / fluorescent signals in 326 
the same range as JW41. A significant increase in fluorescence occurred for JW41 and the 327 
positive control IR800CW-2DG in both cell lines when treated with TPA, whereas there was 328 
no uptake increase observed in cells treated with IR800CW (Supporting Fig. 7). These results 329 
support specific recognition of JW41 by tumor cells via glucose transporters.  330 
In vivo evaluation. The ability to detect the photoacoustic and fluorescence signals of the 331 
capped and uncapped probes in living subjects was studied in subcutaneous MDA-MB-231 332 
tumors in nude mice. Initially, the probes were injected into healthy mice (n=2), which were 333 
kept alive for a month after injection. No signs of toxicity were observed in these mice.  334 
Next, the biodistribution of a 2:1 mixture of JW41-JW35 injected intravenously was evaluated 335 
(Supporting Fig. 8; n=2 mice, n=2 tumors). Spectral unmixing was performed based on the 336 
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measured spectra of the probes and published spectra for oxy- and deoxyhemoglobin27 337 
(Supporting Fig. 8A). Both JW41 and JW35 probes could be successfully distinguished from 338 
each other and the background enabling visualization. An increase in PA signal intensity as 339 
well as a change in the PA spectrum was observed immediately in both the tumors and healthy 340 
organs (Supporting Fig. 8B). Analysis of the JW41:JW35 signal ratio in the liver (the organ 341 
with the highest PA signal following injection) shows that the measured ratio was within 11% 342 
of the expected 2:1 value (Fig. 2). We also analyzed our time course data using the ratio of 343 
the PA signal at 765nm (the isosbestic point of the two probes) to 900nm. The initial uptake of 344 
the mixture in tumors and healthy organs remained over the initial imaging session of 30min 345 
following injection but was diminished by 24h (Supporting Fig. 8C). The accumulation and 346 
retention of the probes was confirmed with fluorescence imaging acquired before probe 347 
injection, 1h post injection as well as 24h after injection (Supporting Fig. 8D, E). Furthermore, 348 
the control regions of interest (illustrated in Supporting Fig. 8A) show an initial rise in PA signal 349 
as the probe mixture circulates in the blood volume of the mouse, but then return to baseline 350 
within 15 min (Supporting Fig. 8F). 351 
Having established that JW35 and JW41 could be resolved in vivo, the capped probe, JW41, 352 
was injected alone (Fig. 5; n=4 mice, n=7 tumors). An increase in PA signal intensity and 353 
change in spectral shape could be observed after injection (Fig. 5A, B). In this case, however, 354 
the strong photoacoustic signal seen immediately after injection persisted for 24h in the tumors 355 
and liver. In comparison to the mixture injection, this indicates that a specific uptake and 356 
retention is seen in the tumors and liver for the capped JW41 probe and that the uncapped 357 
JW35 probe exhibits faster clearance (Fig. 5C). The specific accumulation and retention of 358 
the probe in tumor and liver was confirmed with fluorescence imaging (Fig. 5D, E). Again, the 359 
PA signals in the control regions returned to baseline within 15min (Supporting Fig. 9) 360 
confirming that the kinetics observed are organ specific. Finally, comparing the time course of 361 
the spectrally unmixed signals in the tumor region shows a similar distribution profile to the 362 
ratio of the single wavelengths but with a negligible contribution of the capped JW41 probe by 363 
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24h, as might be expected following complete conversion of the capped JW41 to the 364 
uncapped JW35 (Fig. 5F; Supporting Fig. 10A). The spectral unmixing data for the 2:1 mixture 365 
injection (Supporting Fig. 10B) indeed reflects a 2:1 ratio in the healthy organs, although it 366 
appears closer to 1:1 in the tumor tissue, suggesting parts of the JW41 were already converted 367 
into JW35 within the tumor within the first 5min after injection. Nonetheless, comparing the 368 
signals of JW41 and JW35 in the ROIs of the mice injected with only JW41 to a 2:1 mixture 369 
of JW41:JW35 indicates a conversion of 57±14% of the injected JW41 into JW35 (average 370 
across 7 tumors; time course data in Supporting Fig. 10). These results suggest a good tumor 371 
targeting efficiency and demonstrate the applicability of the probe to undergo conversion in 372 
vivo.  373 
Ex vivo evaluation. Finally, we sought to confirm the localization and conversion of the probe 374 
in the tumors ex vivo excised after the 24h imaging time point. Qualitative comparison of H&E 375 
stained tumor tissue with the probe fluorescence using wide-field microscopy of consecutive 376 
frozen tumor sections (Fig. 6A) suggests that the probe accumulates to a greater extent in 377 
non-necrotic areas. Co-staining with DAPI confirmed that the probe is uptaken into the cytosol 378 
of the cells in vivo as was shown before for in vitro conditions (Fig. 6A zoom; Supporting Fig. 379 
11A, B). To verify the conversion of JW41 into JW35 in vivo, we performed LC-MS/MS 380 
analysis of JW41 and JW35 in tissue extracts to evaluate the concentration of the probes. 381 
JW35 was detected in all tumors, confirming the successful conversion from JW41 in those 382 
mice that received injection of JW41 alone (Supporting Fig. 2E). The total probe concentration 383 
in the liver calculated by LC-MS/MS combined with multiple reaction monitoring mass 384 
spectrometry (MRM-MS) analysis was around 4-fold higher than the probe concentration in 385 
the tumors, which corroborates the 4-fold greater PA signal amplitude in the liver compared to 386 
the tumor regions observed during in vivo imaging. The conversion of JW41 into JW35 in mice 387 
injected with JW41 alone was calculated to be 36±4% (Fig. 6B) in tumor tissue, which is 388 
somewhat lower than the value estimated using PA spectral unmixing. By contrast, the 389 
conversion in the liver tissue was negligible (3±3%). This was expected as the H2O2 production 390 
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in the liver should be relatively small in comparison to the tumor and the PA signals from 391 
spectral unmixing are diminished at the 24h time point (Supporting Fig. 10, Supporting Table 392 
3). The experiment was also completed for the mice treated with the 2:1 JW41:JW35 mixture. 393 
Since the organs were only collected 24h after injection of the probe, the relative amount of 394 
JW35 in the tumors and liver was similar to the mice treated only with JW41, with 39±4% in 395 
the tumor sections and 7±4% in the liver sections. This is again in line with the PA results, 396 
which suggested a faster clearance of JW35. 397 
  398 
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Discussion  399 
New methods for the specific detection and quantification of ROS in vivo are necessary to 400 
advance our understanding of oxidative stress in cancer. Accordingly, we designed a new 401 
targeted photoacoustic and fluorescent probe for the detection of H2O2 and demonstrated 402 
successful application in vitro and in vivo.  403 
Spectral unmixing of PA images allowed the relative quantification of the concentration of the 404 
capped probe, JW41, and the H2O2-transformed uncapped probe, JW35, in tissue mimicking 405 
phantoms with accuracies of ~6%. In vitro studies showed no significant toxicity and specific 406 
uptake of the probe into the cytosol in both MDA-MB-231 and MCF7 cells. The cellular uptake 407 
was increased by treating the cells with TPA, suggesting effective GLUT targeting. Intravenous 408 
injection of the capped probe, JW41, into MDA-MB-231 tumor bearing mice indicated a good 409 
in vivo biodistribution. Uptake and specific accumulation into the tumors and background 410 
accumulation in the liver over 24h were observed in both photoacoustic and fluorescence 411 
imaging and no signs of toxicity were observed in mice monitored over 4 weeks. Specific 412 
changes in PA spectra enabled spectral unmixing to generate images indicating the relative 413 
concentrations of the injected probe, JW41, as well the conversion product, JW35 that were 414 
in reasonable agreement with expectation. Histopathological and wide field microscopy-based 415 
ex vivo examination confirmed heterogenous cytosolic localization of the new probe in tumor 416 
sections and indicated a decreased accumulation in necrotic tumor areas. To validate that 417 
JW41 was converted by H2O2 into JW35 in tumor tissue, LC-MS/MS by MRM-MS analysis 418 
was performed, suggesting around 4-times higher conversion rate of JW41 into JW35 inside 419 
the tumors compared to liver tissue, which is to be expected given the high levels of oxidative 420 
stress in solid tumors compared to normal tissues.  421 
The vast majority of H2O2 responsive probes have been developed for fluorescence or 422 
luminescence imaging.28–31 Unfortunately, all-optical imaging modalities are restricted by light 423 
scattering in tissue to superficial depths and have poor spatial resolution. Near-infrared probes 424 
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have been developed to improve the depth of penetration by accessing the ‘tissue optical 425 
window’,32,33 however, the spatial resolution remains low. Conversely, PAI provides whole-426 
body imaging in small animals (~3cm depth) at high spatial resolution (~150um). Prior reports 427 
of hydrogen-peroxide responsive PAI used untargeted nanoplatforms,34–36 which afforded a 428 
substantial increase in absorbance upon sensitive and specific reaction with H2O2. Yet in all 429 
cases, the absorption spectrum itself was unchanged, making it challenging to discern the 430 
difference between an organ with higher uptake of the nanoplatform from one with higher H2O2 431 
concentration. The nanoplatforms were also relatively large in size (>100nm) and lacked a 432 
specific targeting moiety, relying on passive uptake in the disease state of interest. 433 
Furthermore, induction of oxidative stress by these nanoplatforms, which has been reported 434 
in other nanoparticle studies, was not specifically investigated. Our probe overcomes these 435 
limitations as it is based on a small molecule dye, provides a spectral shift in response to H2O2 436 
and is targeted to the disease site of interest, which enabled direct hydrogen-peroxide 437 
responsive PAI in tumor models. 438 
Despite these promising findings, there are some limitations to the study. The spectral 439 
unmixing approach used shows some signal misclassification, which could arise due to 440 
changes in the probe spectra under physiological conditions in vivo or due to spectral coloring 441 
from depth dependent attenuation of shorter wavelengths. Applying a fluence correction to the 442 
data may improve the latter. Making structural modifications to the probe to generate narrower 443 
peaks and greater spectral differences between the capped and uncapped probe would 444 
enable better distinction of the spectra. An alternative approach would be to create an 445 
absorbing product from a non-absorbing precursor. Another limitation is our targeting of the 446 
probe to cells with increased expression of the GLUT transporters, which can yield off-target 447 
uptake under, for example, inflammatory conditions as exhibited in studies with 18F-448 
fluorodeoxyglucose using positron emission tomography.37 Using a targeting moiety that binds 449 
to a molecular marker that is specific to the cancer cells of interest would allow us to study the 450 
presence of H2O2 while avoiding off-target effects. Finally, we have considered here only 451 
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average signals across the entire tumor volume. Future studies should explore and validate 452 
any heterogeneity in the probe biodistribution and conversion within the tumor. 453 
In summary, our results suggest that this probe could enable the physiology and pathology of 454 
H2O2 to be evaluated in cancer models to provide new insights into oxidative stress biology. 455 
Given the recent translation of PAI into early clinical trials and the high biocompatibility of the 456 
probe, with further refinement, our approach could pave the way to specific imaging of 457 
oxidative stress in solid tumors in patients. 458 
 459 
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Figure legends  574 
Figure 1. Overview of the smart, targeted hydrogen peroxide probe for photoacoustic 575 
and fluorescence imaging. The capped near-infrared probe (JW41) exhibits an increased 576 
accumulation in tumor tissue and an H2O2-dependent change in its photophysical properties 577 
once uncapped (JW35).  578 
 579 
Figure 2. Optical and optoacoustic properties of the capped (JW41) and uncapped 580 
(JW35) probes. (A) Absorption, fluorescence (excitation l = 740 nm) and photoacoustic 581 
spectra of the capped (JW41, 10 µM) and uncapped (JW35, 10 µM) probe in water along with 582 
photostability data. Photoacoustic spectra were recorded in the tissue mimicking phantom 583 
shown in (B). Photostability of 2.5 µM probe solutions was evaluated in tissue mimicking 584 
phantoms under continuous laser exposure showing comparable performance to a widely 585 
used commercial dye. (B) Schematic illustration of experimental set up for phantom 586 
experiments (top) and resulting PA image of the tissue mimicking phantom (bottom) with 587 
regions of interest used for analysis illustrated. The normalized PA spectra shown form the 588 
foundation for subsequent spectral unmixing. (C) Phantom images containing straws filled with 589 
different aqueous JW41-JW35 mixture solutions with adjacent results from spectral unmixing 590 
(see also Supporting Table 2). The weights contributed by the JW41 and JW35 spectra to 591 
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each straw signal are plotted relative to a reference straw (1) containing 1 µM JW35. The 592 
JW35:JW41 mixtures tested were 0:225 (top left), 66.6:33.3 (top right), 50:50 (bottom left) and 593 
33.3:66.6 (bottom right). 594 
 595 
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Figure 3. H2O2 reactivity and specificity. Reaction kinetics of the capped probe (JW41; 10 597 
µM) with H2O2 (100 µM) could be monitored via absorption (A), photoacoustic (B) and 598 
fluorescence (C) spectroscopy. The change in peak absorbance at 730 nm and 790 nm was 599 
used to generate the reaction progress curve (D). Data were acquired in water at 25 °C and 600 
repeated three times. HPLC-UV monitoring at 750 nm of the response of JW41 (10 µM) 601 
towards different ROS (E) after 60 min ([ROS] ~ 100 µM) shows good specificity. JW35 (10 602 
µM) was used as endpoint-reference. It should be noted that JW41 partially hydrolyzes to the 603 
corresponding boronic acid (JW41hydrol.) under aqueous conditions. However, this does not 604 
significantly affect the optical properties of the probe. 605 
 606 
Figure 4. In vitro characterization of JW41 and JW35 in MDA-MB-231 and MCF7 cells. 607 
(A) Incubation with 5 µM JW41/JW35 showed negligible impact on cell proliferation. ICG (5 608 
µM) was used as FDA approved control dye, H2O2 (1 mM) as toxic control compound and DMF 609 
(0.5 %) to correct for possible effects of the solvent used in preparation of the dye stocks. The 610 
substances were added 24 h after the cells were seeded. Statistical significance was assessed 611 
by 2way ANOVA (n = 4); ∗∗∗∗p<0.0001; ∗p>0.024. (B) Cell viability was tested by MTT assay. 612 
Cells were incubated with 5 µM of JW41, JW35, ICG or 0.5% DMF for 8 h (n = 4). 0.5% DMF 613 
was used to correct for the toxicity caused by the solvent of the dyes stock solutions, ICG was 614 
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included as a negative reference being an FDA approved dye and 1 mM H2O2 as a positive 615 
reference causing cell death. (C) Cellular uptake of 2.5 µM JW41 and JW35 in MDA-MB-231 616 
and MCF7 cells was measured at the indicated time points (n = 3). (D) Widefield fluorescence 617 
images of fixed MDA-MB-231 and MCF7 cells stained with JW41/JW35 (red; 2.5 μM, 60min 618 
before fixation), WGA-AF488 (green; 5 μg/mL; 10 min after fixation) and Hoechst (blue; 5 619 
μg/mL; 10 min after fixation) indicates intracellular uptake and cytosolic localization.  620 
  621 
 32 
Figure 5. In vivo characterization of JW41 in subcutaneous MDA-MB-231 tumors in nude 622 
mice. (A) Representative PAI slice through MDA- MB-231 tumors (top row) and kidney, spleen 623 
and liver (bottom row) before and 15-20 min after injection of JW41. The regions of interest 624 
(ROIs) are indicated with white borders (LT = left tumor, RT = right tumor, L = liver, S = spleen, 625 
K = kidney, C = control region). The signal of JW41 is shown in yellow, the signal of the JW35 626 
in magenta. (B) Changes in the PA spectra and an increase in the PA signal between 700 and 627 
810 nm were detected in the ROIs upon injection of JW41. Representative graphs for tumor 628 
(top row) and liver (bottom row) are presented. (C) The time course of the total probe signal 629 
at the isosbestic point of the capped and uncapped probe spectra (765 nm) relative to a long 630 
wavelength that shows negligible absorption is illustrated in tumors and healthy organs up to 631 
24 h after injection. (D) Fluorescence images before, 1 h and 24 h post injection of JW41. (E) 632 
The time course of fluorescent radiant efficiency in the tumors and liver upon JW41 injection 633 
(values from the control region, C, were used for background correction). (F) The time course 634 
of PA signal change evaluated using spectral unmixing.  635 
 636 
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Figure 6. Ex vivo characterization of JW41 and JW35. (A) Representative H&E stained 637 
section of a frozen MDA-MB-231 tumor from a mouse injected with JW41 compared to a 638 
representative widefield fluorescence image of the consecutive tumor section after 639 
formaldehyde fixation and staining with DAPI (blue). The necrotic area is indicated with the 640 
white line. Magnification of the widefield images allowed qualitative confirmation of the 641 
localization of the probe signal into the cytosols of the cells. (B) Quantification of the amount 642 
of JW41 present in the tumors and livers being converted into JW35 based on LC-MS/MS by 643 
MRM-MS analysis (conversion rate in mole %).  644 
 645 
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